INNOPHARMAX INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.95 TWD | -3.23% |
|
+3.16% | +3.16% |
| 04-19 | InnoPharmax Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | InnoPharmax Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 52.27M | - | - | - | - | - | |
| 43.81B | ||||||
| 23.03B | ||||||
| 15.45B | ||||||
| 14.4B | ||||||
| 12.95B |
- Stock Market
- Equities
- 4172 Stock
- Charts InnoPharmax Inc.
- Sector Chart
